Rights and permissions
About this article
Cite this article
Ramipril cost effective in patients at high risk for cardiovascular events. Pharmacoecon. Outcomes News 464, 5 (2004). https://doi.org/10.2165/00151234-200404640-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404640-00011